Stocks to Watch: AMC Entertainment, Becton Dickinson and Verrica Pharmaceuticals
Provided by
Dow Jones
By Denny Jacob
AMC Entertainment's proposed equity transactions were blocked after a judge rejected a proposed court settlement. Shares surged 74% in after-hours trading.
Medical technology company Becton Dickinson's updated BD Alaris Infusion System received 510(k) clearance from the Food and Drug Administration. Shares climbed 5.9% in aftermarket trading.
Verrica Pharmaceuticals' Ycanth topical solution for the treatment of molluscum contagiosum in adults and patients ages two and up was approved by the Food and Drug Administration. Shares slip 12% in after-hours trading.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
July 21, 2023 19:13 ET (23:13 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth